Psoriasis Treatment Market Key Highlights:
- Market Size (2024): USD 15.83 Billion
- Projected Market Size (2034): USD 32.93 Billion
- CAGR (2023-2034): 7.6%
Pricing Analysis:
- Price Growth
- Regional Variations
Market Historic Sales
- Total sales volume, year-over-year growth, product categories, and market share.
Revenue Estimation
- Forecasting future revenues based on historical data, market trends, and economic indicators.
Sales by Region
- Breakdown of sales performance across different geographical areas.
Revenue by Manufacturer
- Analysis of revenue contributions from different manufacturers in the market.
Psoriasis Treatment Market Definition
The psoriasis treatment market deals in the manufacturing and distribution of drugs for treating psoriasis across the world. There are various types of drug classes used in the treatment of this disease, including TNF inhibitors, interleukin inhibitors, and some others. The main products manufactured by this industry include biologics and non-biologics. These medicines are available on online and offline platforms. This market is likely to rise significantly with the growth of the pharmaceutical industry across the world.
The growing prevalence of several types of psoriasis diseases, such as plaque psoriasis, psoriatic arthritis, and some others, has driven the market growth. Also, the rising awareness regarding psoriasis, along with advancements in the healthcare sector regarding the treatment of autoimmune disorders, has positively shaped the industry. Moreover, the increased application of oral, topical, and parenteral/systemic medications for psoriasis treatment, along with the increasing availability of these medicines in hospital pharmacies and retail pharmacies, is expected to drive the growth of the psoriasis treatment market.
The advancements in phototherapy technology along with rising adoption of combination therapies for psoriasis treatment is expected to create ample growth opportunities for the market players in the upcoming days. In September 2022, the U.S. Food and Drug Administration (FDA) announced the approval of Sotyktu. Sotyktu is an oral treatment that is used in the treatment of moderate-to-severe plaque psoriasis.
Psoriasis Treatment Market Segmentation:
By Type
- TNF Inhibitors
- Phosphodiesterase Inhibitors
- Interleukin Blockers
- Others
By Application
Psoriasis Treatment Market Companies:
- Novartis International AG
- Johnson & Johnson
- Pfizer Inc.
- Merck and Co. Inc.
- AbbVie and Amgen
- Eli Lilly.
For any questions about this dataset or to discuss customization options, please write to us at sales@statifacts.com
